Peptides 101 · Peptide Guide
One of the most common frustrations people have when researching peptide therapy is that the information available online is either vague (“results may vary”) or suspiciously optimistic…
This guide gives you the honest version: what the process actually looks like from start to finish, what labs a clinician will typically want before you begin, how peptides are administered, what a realistic timeline of effects looks like, what side effects are common versus what should prompt you to stop, and who this genuinely isn’t appropriate for.
A properly structured peptide therapy program follows a predictable sequence. If a provider is skipping steps, particularly the consultation and labs, that is a meaningful red flag.
1
The process begins with a thorough one-on-one consultation with a licensed clinician, typically a physician, nurse practitioner, or physician assistant with experience in functional or metabolic medicine. This is not a brief intake form: it is a detailed conversation covering your full medical history, current medications and supplements, previous treatments, lifestyle factors, and your specific health goals.
A consultation of this nature typically takes 45 minutes to an hour for a new patient. The clinician will be evaluating not just whether peptide therapy is appropriate, but which specific peptide or combination of peptides, and at what dose and frequency, makes the most sense for your individual profile.[1]
They should also be assessing for contraindications: conditions or circumstances that would make specific peptides inadvisable. This conversation should be genuinely two-way, if a provider is prescribing without asking detailed questions, that is concerning.
2
Before any peptide is prescribed, a responsible clinician will order baseline laboratory testing. This serves two purposes: confirming you are an appropriate candidate, and establishing baseline values to measure your response against later.[2]
The specific labs ordered will depend on which peptides are being considered, but a comprehensive baseline typically includes a complete blood count (CBC), comprehensive metabolic panel (CMP), thyroid function tests, and a relevant hormone panel. For growth hormone secretagogues specifically, IGF-1 levels and fasting glucose are standard. For anyone over 40 or with cardiovascular risk factors, a lipid panel and cardiovascular markers are also appropriate.
Labs typically take 3–7 business days to return. Your clinician will review the results with you before finalising any protocol.
3
Once lab results are reviewed, your clinician will design a personalised protocol. This includes the specific peptide or peptides, the dose, the frequency of administration, the timing (some peptides are most effective at specific times of day or in relation to sleep), and the duration of the initial cycle.
The prescription is sent to a licensed compounding pharmacy, which will prepare your peptides to pharmaceutical-grade standards. Turnaround from prescription to delivery is typically 5–10 business days. You should receive your medication along with administration instructions and a Certificate of Analysis confirming purity and potency.
Your clinician or their team should walk you through the administration protocol before you begin, including how to reconstitute a lyophilised (freeze-dried) peptide if applicable, how to draw and administer a subcutaneous injection, storage requirements, and what to do if you miss a dose.[3]
4
Most therapeutic peptide protocols begin with a lower introductory dose for the first 1–2 weeks before titrating up to the target dose. This “ramp-up” period allows your body to adjust and helps identify any immediate adverse reactions before you are at a full therapeutic dose.
Keeping a simple symptom diary during the first 4–6 weeks is strongly recommended. Note energy levels, sleep quality, injection site reactions, mood, and any unexpected changes. This information is genuinely useful at your follow-up appointment and helps your clinician make informed adjustments.
5
Peptide therapy is not a set-and-forget treatment. A well-run program includes scheduled follow-up appointments, typically at 4–6 weeks, then at 3 months, then quarterly or as clinically indicated. Follow-up labs are used to assess your biological response to the protocol and check for any changes in markers that warrant dose adjustment.
Your clinician should be accessible between appointments if you have concerns or experience unexpected effects. A protocol that has no monitoring structure is not being managed responsibly.[4]
6
Based on your lab results and reported experience, your clinician will review and potentially adjust your protocol. This might mean changing the dose, modifying the timing, cycling off a peptide temporarily, or adding a complementary compound. Most protocols are reviewed and refined over a 3–6 month window before a longer-term approach is established.
It is also entirely appropriate, and in fact healthy, for you and your clinician to periodically reassess whether continuing therapy is warranted. Goals evolve, circumstances change, and a good clinician will always be asking whether the benefit-risk calculation still makes sense for you.
The specific labs ordered before starting peptide therapy vary by clinician and by the peptides being considered. The table below gives a general overview of common baseline markers and why each is relevant:
| Lab Test | What It Measures | Why It Matters for Peptide Therapy |
|---|---|---|
| Complete Blood Count (CBC) | Red cells, white cells, platelets | Establishes baseline immune and haematological health; identifies anaemia or immune disorders |
| Comprehensive Metabolic Panel (CMP) | Kidney, liver, glucose, electrolytes | Assesses organ function and metabolic baseline; flags conditions that affect peptide metabolism |
| IGF-1 (Insulin-like Growth Factor 1) | Downstream marker of growth hormone activity | Essential for GH secretagogue protocols; used to guide dosing and monitor response |
| Fasting Glucose / HbA1c | Blood sugar regulation | Relevant for GLP-1 agonists and GH peptides; important for monitoring metabolic effects |
| Thyroid Panel (TSH, T3, T4) | Thyroid hormone levels | Thyroid dysfunction can affect peptide response and energy levels |
| Testosterone / Oestrogen / DHEA | Sex hormone levels | Baseline for hormone-adjacent peptide protocols; detects existing imbalances |
| Lipid Panel | Cholesterol and triglycerides | Baseline cardiovascular risk assessment; some peptides affect lipid profiles |
| C-Reactive Protein (CRP) | Systemic inflammation marker | Relevant for repair and recovery peptides; monitors anti-inflammatory effects |
The most common administration route for therapeutic peptides is subcutaneous injection, a small needle inserted just beneath the skin, typically into the abdomen or thigh. If this sounds daunting, it is worth noting that the needles used are very fine (typically 29–31 gauge, similar to insulin needles), and most patients find the process straightforward after the first few attempts. Injection site discomfort is generally minimal.[3]
Peptides are injected subcutaneously rather than intravenously because they need to be absorbed gradually through the surrounding tissue, the subcutaneous route mimics the body’s natural peptide release pattern more closely than a direct intravenous bolus. Your clinician or pharmacy should provide detailed instructions and demonstrate the technique before you administer your first dose.
Depending on the peptide and the goal, some protocols use alternative delivery methods:
Most compounded peptides arrive as lyophilised (freeze-dried) powder in sealed vials, which must be reconstituted with bacteriostatic water before use. Reconstituted peptides are typically stored in the refrigerator and used within a defined window (usually 28–60 days, depending on the compound). Unopened vials should be kept frozen until needed. Your pharmacy will provide specific storage instructions, follow them carefully, as improper storage can degrade the peptide.
One of the most important expectations to set correctly is the timeline. Peptide therapy is not a quick fix. Changes occur gradually as the body’s biological systems respond to sustained signalling, not overnight. The following timeline reflects general patterns for growth hormone secretagogue and repair peptide protocols:
Weeks 1–2
Adjustment period
Most people notice very little during this phase. Some mild injection site reactions (redness, minor swelling) are common and expected. You may notice slight changes in sleep depth or quality, this is often one of the earliest effects of GH-related peptides and is a positive sign of biological activity.
Weeks 2–4
Early effects
Improved sleep quality and slightly increased energy are frequently the first effects reported. Some patients describe a subjective sense of improved recovery after exercise. Changes in body composition, weight, or measurable hormonal markers are not expected this early.
Weeks 4–8
Building effects
Energy levels and recovery tend to become more consistently noticeable. Some patients begin to observe subtle changes in body composition (reduced water retention, early lean mass changes). For GLP-1 agonists, appetite reduction and weight changes may be noticeable from the first few weeks. For repair peptides like BPC-157, patients with specific injury or gut complaints may notice functional improvements.
Weeks 8–12
Measurable changes
This is typically when meaningful, objectively measurable changes begin to appear. IGF-1 levels (for GH secretagogues) will have shifted. Body composition changes become more apparent. Follow-up labs at 8–12 weeks provide the first clear biological readout of how you are responding to the protocol.
Months 3–6
Full protocol effects
By 3–6 months, the cumulative biological effects of sustained peptide signalling are fully established. This is the window in which most patients experience their most significant measurable changes. Protocol adjustments based on labs and clinical response are made at this stage.
Important Expectation
Individual variation is real and significant. Two people on the same peptide at the same dose can have noticeably different response timelines based on age, baseline hormone levels, metabolic health, sleep quality, nutrition, and genetics. A timeline that worked for someone else may not be your timeline, and that is normal, not a sign that the therapy is failing.
The general principle: mild, transient side effects that resolve within the first 1–2 weeks are common and not a cause for concern. Anything persistent, severe, or that affects your cardiovascular system warrants prompt contact with your prescribing clinician, not a Google search.[4]
Peptide therapy is not a universal option. There are genuine contraindications, medical circumstances in which specific peptides (and in some cases all peptides that stimulate growth pathways) should not be used.
⚠️ Absolute and Relative Contraindications, Discuss with your clinician
Peptide therapy is a medical intervention, not a lifestyle replacement. How well it works is significantly affected by the context into which it is introduced. Clinicians who run structured peptide programs consistently observe that patients who optimise the following lifestyle factors get better results, and that patients who neglect them often plateau or don’t respond as expected.
Many therapeutic peptides, particularly growth hormone secretagogues, work by amplifying the body’s natural GH pulse, which occurs primarily during deep sleep. If you are chronically sleep-deprived or have disordered sleep, the efficacy of these peptides is meaningfully reduced. Addressing sleep hygiene is one of the most impactful things you can do alongside a GH peptide protocol.
For protocols targeting body composition, lean muscle, and recovery, resistance training is not optional, it is part of the mechanism. Peptides that signal tissue repair and growth hormone production work synergistically with the signals generated by exercise-induced muscle stress. Sedentary patients using these protocols typically see significantly less benefit.
Peptides can signal the body to build and repair, but they cannot build tissue out of nothing. Adequate dietary protein provides the raw material for the processes being signalled. Most clinicians prescribing body composition protocols recommend a protein intake of 1.6–2.2g per kilogram of body weight daily as a baseline.
Regular alcohol consumption blunts growth hormone secretion, impairs sleep architecture, and places additional load on the liver, all of which reduce the efficacy of peptide protocols. Your clinician should ask about alcohol use as part of the intake conversation, and some protocols will include specific guidance on this.
A properly run peptide therapy program is characterised by patience, personalisation, and professional oversight at every stage. It starts with a thorough consultation and baseline labs. It involves a prescription to a licensed pharmacy and pharmaceutical-grade compounds. It includes clear instructions for administration, realistic expectations for timeline, and scheduled follow-up monitoring.
It is also characterised by honesty about what it cannot do. Peptide therapy is a tool, one with genuine clinical utility in the right context, under the right conditions, for the right person. It is not a shortcut, not a substitute for fundamental health practices, and not appropriate for everyone.
The patients who get the most from peptide therapy tend to be those who approach it as part of a broader, medically guided health strategy, not as a standalone fix. That orientation, combined with qualified clinical support and pharmaceutical-grade products, is the foundation of everything that follows.
Our free quiz takes 3 minutes and helps you understand your goals, your candidacy, and what a next step might look like, before you speak to a clinician.